"Drugs in Indian markets safer than those in the US, Europe: WHO’s monitoring agency"steemCreated with Sketch.

in #health6 years ago

Only 2% of the medical products in Southeast Asia, including India, were spurious against a global figure of 10.5%, according to WHO’s Global Surveillance and Monitoring System.

The growing global trade in medicines has also opened door to drugs, vaccines and other medical products that do not meet quality standards and are even toxic at times.
At a time when quality of Indian medicines is being questioned, a WHO agency has found that only 2% of the medical products in Southeast Asia, including India, were substandard or spurious against a global figure of 10.5%.

Effectively, it means medicines and medical products available in India are safer than what is available in American and European markets.

Nearly 10.5% of the samples collected by WHO’s Global Surveillance and Monitoring System for substandard and falsified medical products (GSMS) between 2013-17 failed quality test, says the report released on Tuesday. It defines falsified medical products as those that misrepresent identity, composition or source.

In the past spotlight has largely been on lifestyle medicines such as slimming tablets, the WHO findings show that everything — from cancer medicines to contraception, antibiotics to vaccines — faces a quality problem across the world.

Substandard drugs and vaccines up the risk of several diseases becoming difficult to treat and the world left grappling with antimicrobial resistance, which is a growing concern.

Coin Marketplace

STEEM 0.35
TRX 0.12
JST 0.039
BTC 69796.92
ETH 3521.66
USDT 1.00
SBD 4.70